Boehringer Ingelheim International GmbH：
   

Please note that on November 4, 2026, CDI sent the Notification of Drug Remote Inspection Results of Zongertinib Tablets to the agency of the medicine in China.
   

If there are any questions, please do not hesitate to contact us as soon.
   

Contact: Zhan Jinbao
   

Tel.+86 10 68441663

Center for Drug Inspection of NMPA
November 4, 2026